Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited

TKPHF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$68.02B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Takeda Pharmaceutical Company LimitedTakeda Pharmaceutical Company Limited28.32.92%5%-0.6
$43.69

Current Fair Value

1.5% upside

Undervalued by 1.5% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$68.02 Billion
Enterprise Value$4.34 Trillion
Annual dividend$1.28
Dividend yield2.92%
Earnings per Share$123.03
Beta0.09
Outstanding Shares1,579,922,000

Return

Return on Equity5.21%ROE
Return on Assets2.53%
Return on Invested Capital5.96%

Valuation & Multiples

P/E Ratio28.29P/E Ratio
PEG-1.63PEG
Price to Sales0.01Price to Sales
Price to Book Ratio0.01Price to Book Ratio
Enterprise Value to Revenue0.92
Enterprise Value to EBIT5.75
Enterprise Value to Net Income11
Total Debt to Enterprise1.08
Debt to Equity0.63Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
October 29, 2026
EPS
$0.77
Est. $0.29
Revenue
$7.54 B
Est. $7.35 B

Next Earnings Call

Expected Date
January 28, 2027
EPS Estimate
$0.28
Consensus analyst estimate
Revenue Estimate
$7.53 B
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Takeda Pharmaceutical Co

47,029 employees
CEO: Christophe Weber

Takeda Pharmaceutical Company Limited is a global biopharmaceutical enterprise engaged in the discovery, development, manufacturing, marketing, and out-licensing of various medical products. The company's operations span Japan, the Unite...